PrimCHIX:PRME 69 FCF Yield % is 7.96 as of Jun. 27, 2026, which is 2962% above its 10-year median of 0.26. GuruFocus rates CHIX:PRME with a GF Score™ of 69/100 and a GF Value™ of €5.69. The stock has 4 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Prim ranks better than 91.11% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Prim's Trailing 12-Month Free Cash Flow is €18.1 Mil, and Market Cap is €227.9 Mil. Therefore, Prim's FCF Yield % for today is 7.96%.
The historical rank and industry rank for Prim's FCF Yield % or its related term are showing as below:
CHIX:PRMe'
s FCF Yield % Range Over the Past 10 Years
Min: -13.11 Med: 0.26 Max: 11.2
Current: 7.96
During the past 13 years, the highest FCF Yield % of Prim was 11.20%. The lowest was -13.11%. And the median was 0.26%.
CHIX:PRMe's FCF Yield % is ranked better than 91.11% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: -0.38
vs CHIX:PRMe: 7.96
Prim's FCF Margin % for the quarter that ended in Dec. 2025 was 12.99%.
Prim FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Prim FCF Yield % Related Terms
Prim FCF Yield % Historical Data
* Premium members only.
The historical data trend for Prim's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:PRME vs ISRG, BDX, MDLN: FCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, Prim's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prim FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Prim's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Prim's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prim (CHIX:PRME) has a FCF Yield % of 7.96 as of Jun. 27, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Prim and its competitors. This is 2962% above median its historical median of 0.26. According to the industry distribution chart, Prim ranks #76 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 8.9%.
Is Prim's FCF Yield % too high?
Prim's current FCF Yield % of 7.96 is 2962% above median its 10-year median of 0.26. Based on the distribution chart, Prim ranks #76 out of 855 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Prim has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Prim's FCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Prim ranks #76 out of 855 companies for FCF Yield %. This places Prim in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Prim and its competitors. Prim's current FCF Yield % is 7.96, which is 2962% above median its own 10-year median of 0.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prim stock overvalued right now?
Prim (CHIX:PRME) has a current FCF Yield % of 7.96. The stock's GF Value™ is €5.69, compared to a current price of €10.90 — trading 91.6% above its estimated fair value. The current FCF Yield % is 7.96, which is 2962% above median its 10-year median of 0.26. Prim's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Prim (CHIX:PRME), the current FCF Yield % is 7.96 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Prim (CHIX:PRME) Overvalued in 2026?
Based on GuruFocus' analysis, Prim stock appears to be overvalued.
The current stock price of €10.90 is trading 91.6% above its estimated GF Value™ of €5.69.
Key valuation signals for CHIX:PRME:
FCF Yield %: 7.96 (2962% above median its 10-year median of 0.26)
GF Value™: €5.69 vs. price of €10.90 (91.6% above fair value)
No single metric tells the full story. See the CHIX:PRME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Prim SA is engaged in the provision of hospital supplies. The company is in a hospital and orthopedic supplies and materials for physiotherapy, thalassotherapy, thermal therapy, rehabilitation, geriatrics, as well as daily living aids. Prim work across a division of healthcare units such as Operating Theatres; Pain Management Centres; Plastic Surgery; Endosurgery and Cardiovascular.
69GF Score
Get the complete analysis for CHIX:PRME
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:PRME has been successfully added to your 
